# Ian Ford

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ian-ford/

## Facts

| Field | Value |
| --- | --- |
| Citations | 69,938 |
| Field | Cardiac Imaging and Diagnostics |
| h-index | 120 |
| i10-index | 364 |
| Last Known Institution | MRC Biostatistics Unit |
| OpenAlex ID | https://openalex.org/A5016095791 |
| ORCID iD | 0000-0001-5927-1823 |
| Works | 640 |

## Researcher papers

Showing 12 of 22.

- [Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia](https://scholariq.org/papers/prevention-of-coronary-heart-disease-with-pravastatin-in-men-with/)
- [Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial](https://scholariq.org/papers/pravastatin-in-elderly-individuals-at-risk-of-vascular-disease-prosper-a/)
- [Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy](https://scholariq.org/papers/clinical-features-and-outcomes-of-takotsubo-stress-cardiomyopathy/)
- [Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials](https://scholariq.org/papers/statins-and-risk-of-incident-diabetes-a-collaborative-meta-analysis-of/)
- [Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial](https://scholariq.org/papers/primary-care-led-weight-management-for-remission-of-type-2-diabetes-direct-an/)
- [SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe](https://scholariq.org/papers/score2-risk-prediction-algorithms-new-models-to-estimate-10-year-risk-of/)
- [Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study](https://scholariq.org/papers/metabolic-syndrome-with-and-without-c-reactive-protein-as-a-predictor-of/)
- [Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial](https://scholariq.org/papers/spironolactone-versus-placebo-bisoprolol-and-doxazosin-to-determine-the-optimal/)
- [Diffuse axonal injury in head injury: Definition, diagnosis and grading](https://scholariq.org/papers/diffuse-axonal-injury-in-head-injury-definition-diagnosis-and-grading/)
- [Biochemical detection of left-ventricular systolic dysfunction](https://scholariq.org/papers/biochemical-detection-of-left-ventricular-systolic-dysfunction/)
- [Cardiac-Resynchronization Therapy in Heart Failure with a Narrow QRS Complex](https://scholariq.org/papers/cardiac-resynchronization-therapy-in-heart-failure-with-a-narrow-qrs-complex/)
- [Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials](https://scholariq.org/papers/efficacy-and-safety-of-statin-therapy-in-older-people-a-meta-analysis-of/)

## Researcher topics

- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)
- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Acute Ischemic Stroke Management](https://scholariq.org/topics/acute-ischemic-stroke-management/)

## Researcher university

- [MRC Biostatistics Unit](https://scholariq.org/institutions/mrc-biostatistics-unit/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.